Piceid

BioHarvest Sciences Inc. Exceeds VINIA Israel Sales Orders Expectations for Q4/2020 and Doubles Its 2021 Forecast

Retrieved on: 
Thursday, January 7, 2021
Business, Supply chain management, Piceid, Resveratrol, Sales order, Sales, Articles, Economy

Sales orders received in Q4, 2020 represent a 416% increase over sales orders received in Q4, 2019.

Key Points: 
  • Sales orders received in Q4, 2020 represent a 416% increase over sales orders received in Q4, 2019.
  • Based on the demonstrated demand for VINIA, the company is increasing its 2021 Israel sales order forecast by 100% to US$1,400,000 as compared with its initial sales order forecast of US$700,000.
  • Customers in Israel recognize the superiority of the Piceid Resveratrol available only in VINIA at concentration levels that are able to provide functional benefits.
  • Based in Vancouver B.C., BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology.